NASDAQ:ADIL

A year in review: Adial Pharmaceuticals Inc (ADIL)’s performance in the last year
Arcelia Reed
While Adial Pharmaceuticals Inc has underperformed by -8.14%, investors are advised to look at stock chart patterns for technical insight. ...





